The president's state visit comes amid tensions with carmaker Toyota over potential auto tariffs. Trump has repeatedly threatened Japanese and European carmakers with tariffs.Traderead more
Microsoft shares have gained 133% since November 2015, outperforming a tech "basket of unicorns" over that stretch.Technologyread more
Buybacks have gotten a bad rap from both Republicans and Democrats. But stocks would be trading at a massive discount without them.Marketsread more
The IRS is about to release a new draft of Form W-4, which will more closely reflect the changes stemming from the Tax Cuts and Jobs Act. For workers, that means they'll need...Personal Financeread more
The Mega Millions jackpot has spilled over $400 million. It would be the ninth largest winning since the game began in 2002.Personal Financeread more
When commercial real estate investor Manny Khoshbin spent $2.2 million on the fastest production car in the world, he had no idea it would very quickly also become the...Autosread more
Trump was speaking at a meeting of Japanese business leaders in Tokyo during his state visit to Japan on Saturday.Marketsread more
The biggest U.S. gasoline price surge in years is running out of steam just in time for the start of the summer driving season.Energyread more
The federal minimum wage has remained $7.25 per hour since 2009. But several states, and even some companies, have since taken matters into their own hands to pay employees a...Workread more
Stocks rose on Friday, but notched weekly losses as investors worried the U.S.-China trade war is hurting economic growth.US Marketsread more
President Donald Trump, who has repeatedly attacked pharmaceutical companies for "getting away with murder," wants to do more to address drug prices, Health and Human Services Secretary Alex Azar said Wednesday.
HHS is working with Trump to create a comprehensive strategy to address issues that are causing ever-increasing drug prices, Azar said in a speech at the World Health Care Congress. The agency will build on proposals laid out in Trump's budget proposal for 2019, he said.
"But I can assure you the president wants to go further. Much further. Action is desperately needed," Azar said. "There's little access for a sick patient between a miracle cure that hasn't been discovered and one that is too expensive to use."
Trump criticism of drug prices includes chastising foreign countries for setting price controls on medication and "freeloading" on American innovation.
The Trump administration plans to address high list prices and rising out-of-pocket costs for consumers, said Azar, a former executive at pharmaceutical company Eli Lilly. He said it's possible to lower prices without inhibiting research and development.
"I believe we can lower the cost of medicine while still promoting research that will transform the future of health care going forward," Azar said. "Doing both is the only way forward."
The administration will also address the issue of seniors in government programs overpaying for drugs due to lack of negotiating of negotiating tools, Azar said. He has rejected the idea of allowing Medicare to directly work with manufacturers on prices.
However, the administration's 2019 budget called for some changes. That includes moving some costly drugs from Medicare Part B to Medicare Part D, where private insurers who administer plans can negotiate with manufacturers.
Azar said the administration wants to tackle the problem of foreign governments "freeriding" on American investment and innovation. The White House released a white paper in February calling for a way to get foreign countries to pay more for drugs.
Trump is expected to address drug prices in a speech next week.
He's given his administration "a very strong mandate" to do something about fixing the health-care system, Azar said.
"The time has simply come for this to happen. The status quo just cannot hold," Azar said. "The way we do business in American health care, from insurance to (information technology) to drug pricing to patient billing, has got to change."